Provenance mapping of immune cells in the CSF

A12

The initial phases of immunopathology in the CNS in MS are dictated by the systemic immune compartment. However, it is unknown in which sites of the immune system specific properties of immune cells that later traffic to the CNS are imprinted. Here, we will use an in vivo labeling system to track immune cells from the inguinal (iLN) or mesenteric lymph nodes (mLN) to the CNS. By single cell analysis of the transcriptome and the TCR and BCR of lymphocytes re-isolated from the CNS and cerebrospinal fluid of EAE mice, we will correlate the mesenteric or inguinal provenance of these lymphocytes with their distinct properties in the CNS. We hypothesize that distinct transcriptional profiles are imprinted in T cells according to their site of priming in the peripheral immune compartment. This transcriptional program will later determine their positioning and functional specialization in the CNS. Based on this we ask::

    1. Specific properties are imprinted in in lymphocytes in distinct niches of the secondary lymphoid organs. Does this determine the functional phenotype of these lymphocytes in the CNS and in the CSF??
    2. In certain differential transcriptional modules in CNS T cells we find guidance molecules (integrins, chemokine receptors, cytoskeleton molecules, etc). Are they organized depending on whether they were primed in iLN or mLN?
    3. We will analyse known T helper cell subset modules: Are they differentially expressed in iLN derived vs mLN derived T cells recovered from the CNS?
    4. We will analyse tolerogenic or pathogenic modules. Are they differentially expressed in iLN vs mLN derived CNS T cells?

Single cell (sc) RNAseq analysis (10X) of
photoconverted T cells derived from the inguinal
vs mesenteric lmyph nodes: Inguinally (i) or
mesenterically (m).

 

 

 

 

Principal Investigators:

Univ.-Prof. Dr. med. Thomas Korn
Klinik für Neurologie
TU München
thomas.korn@tum.de

Priv.-Doz. Dr. med. Klaus Lehmann-Horn
Klinik für Neurologie
TU München
klaus.lehmann-horn@tum.de

News

Mon, 09/08/2021
Dietary conjugated linoleic acid links reduced intestinal inflammation to amelioration of CNS autoimmunity
A close interaction between gut immune responses and distant organ-specific autoimmunity including the CNS in multiple sclerosis has been established in recent years. This so-called gut-CNS axis can be shaped by dietary factors, either directly or via indirect modulation of the gut microbiome and its metabolites. Here, SFB 128 PI Luisa Klotz and colleagues report […]...more
Thu, 28/01/2021
BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced the publication of preclinical data on its novel mRNA vaccine approach against autoimmune diseases in the peer-reviewed journal Science. The publication titled “A non-inflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis” co-authored by SFB principal investigator Ari Waisman summarizes the findings on the disease-suppressing effects […]...more
Wed, 20/01/2021
A new study on neurological manifestations of severe COVID-19 reveals nervous system immune deficiency
Patients suffering from COVID-19 can develop concomitant and long-term symptoms in their nervous system. The most common symptom in this context is the loss of the sense of smell and taste, while more severe symptoms such as stroke, cerebral seizures, or meningitis are possible. A team of scientists from the medical faculties at the Universities […]...more